Sleep Health, 2026
Association of insomnia and its proteomic signatures with incident heart failure: A European population-based study

Fei M., Lin Z., Tu J. et al.

GigaScience, 2026
High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases

Li Y., Zhai R., Yang Z. et al.

BMC Cancer, 2025
Allostatic load and kidney cancer incidence and mortality: a genetic susceptibility and proteomic mediation analysis

Xu C., Huo D., Liu Y. et al.

Diabetes Care, 2025
Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes

Xie R., Vlaski T., Trares K. et al.

Cardiovascular Diabetology, 2025
Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease

Li Y., Li D., Lin J. et al.

Advanced Science, 2024
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention

Youhanna S., Kemas A., Wright S. et al.

Journal of Gastroenterology and Hepatology, 2024
Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization

Zhu W., Fan C., Liu B. et al.

Acta Neuropathologica Communications, 2024
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study

Fontanilles M., Heisbourg J., Daban A. et al.

Diabetes Care, 2024
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes

Yao P., Iona A., Pozarickij A. et al.

Science Translational Medicine, 2023
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma

Schmassmann P., Roux J., Buck A. et al.

Frontiers in Cardiovascular Medicine, 2022
Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis

Bracco Gartner T., Crnko S., Leiteris L. et al.

Diabetologia, 2018
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes

Nowak, C., Carlsson et al.

Frontiers in Immunology, 2026
Circulating IL-17A accumulation reflects effective target blockade with secukinumab in spondyloarthritis

Martínez-Moreno J., Llamas-Urbano A., Romero-Zurita L. et al.

Frontiers in Immunology, 2026
Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection

Fineschi S., Klar J., Schuster J. et al.

JHEP Reports, 2026
A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action

Rohbeck E., Niersmann C., Dewidar B. et al.

Journal for ImmunoTherapy of Cancer, 2026
CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis

Wang L., Yang G., Lei H. et al.

Frontiers in Psychiatry, 2026
Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression

Li Z., Jiao Z., Peng M. et al.

PROTEOMICS – Clinical Applications, 2026
A Network‐Based Association of IBD and Colorectal Cancer Using Proteomics Data

Dhami J., Radhakrishnan S., Russ D. et al.

The Journal of Maternal-Fetal & Neonatal Medicine, 2026
Causal relationship between 91 inflammatory factors and fetal growth restriction: a bidirectional Mendelian randomization study

Shen J., Chen X., Fang R. et al.

Nature Communications, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Hamid O., Ekström-Rydén V., Mehmi I. et al.